Beta-adrenergic blockade and the gastrointestinal system.
As beta-adrenergic blockers grow increasingly popular for the therapy of a wide variety of disorders, it becomes increasingly important to appreciate the spectrum of physiologic effects on the gastrointestinal system and the potential hazards associated with use of these agents. This review details the effects of the beta-adrenergic blocking agents on the gastrointestinal tract.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000818:Animals; D001652:Bile Ducts / Q000187:drug effects; D004064:Digestive System / Q000187:drug effects*; D004347:Drug Interactions; D005743:Gastrectomy / Q000009:adverse effects; D005744:Gastric Acid / Q000378:metabolism; D005755:Gastrins / Q000378:metabolism; D005769:Gastrointestinal Motility / Q000187:drug effects; D006801:Humans; D007003:Hypoglycemia / Q000188:drug therapy; D007408:Intestinal Absorption / Q000187:drug effects; D007413:Intestinal Mucosa / Q000378:metabolism; D010179:Pancreas / Q000187:drug effects; D010538:Peritonitis / Q000139:chemically induced; D011941:Receptors, Adrenergic / Q000187:drug effects
D000319:Adrenergic beta-Antagonists; D005755:Gastrins; D011941:Receptors, Adrenergic